Haema 2012; 3(2): 109-116
by Nora Viniou, Panagiotis Diamantopoulos
1st Dept of Internal Medicine, University Medical School of Athens, “Laiko” General Hospital
Haema 2012; 3(2): 109-116
by Nora Viniou, Panagiotis Diamantopoulos
1st Dept of Internal Medicine, University Medical School of Athens, “Laiko” General Hospital
Haema 2012; 3(2): 117-124
by Nikolaos Giannakoulas, Panagiota Matsouka
Hematology Clinic, University Medical School of Thessalia, General Hospital of Larissa
Continue reading “Hypoplastic and fibrotic myelodysplastic syndromes (MDS)”
Haema 2012; 3(2): 125-133
by Alexandros Makis1, Georgia Avgerinou2, Sophia Polychronopoulou2
1Child Health Department, University of Ioannina Medical School, Ioannina, Greece,
2Department of Paediatric Haematology-Oncology, “Aghia Sophia” Children’s Hospital, Athens, Greece
Haema 2012; 3(2): 134-142
by Alexandra Kourakli–Simeonidou, Argiris Simeonidis
Hematology Division, Dept of Internal Medicine, University of Patras Medical School, Patras
Haema 2012; 3(2): 143-150
by Maria Psillaki, Katerina Pirovolaki, Helen A. Papadaki
Hematology Clinic, University Hospital, Heraklion, Crete
Haema 2012; 3(2): 151-157
by Athanasios Galanopoulos
Hematologist, General Hospital «G. Gennimatas», Athens
Haema 2012; 3(2): 158-174
by Vassiliki Pappa
Assistant Professor of Hematology, Medical School University of Athens, Second Department of Internal Medicine and Research Institute, Attikon University General Hospital, Athens, Greece
Continue reading “Treatment options for patients with high risk Myelodysplastic syndromes”
Haema 2012; 3(2): 175-182
by Ioanna Sakellari
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece